Patanjali and AIIMS Bhopal partner to develop holistic treatment solutions

AIIMS Bhopal has taken a historic step toward integrating Indian systems of medicine with modern healthcare through a Memorandum of Understanding (MoU) signed with the Patanjali Research Foundation Trust. This collaboration aims to promote joint research, education, and innovation by combining allopathic medical science with ancient Ayurvedic knowledge to offer comprehensive and effective healthcare solutions.

The MoU was signed in the presence of AIIMS Bhopal’s Executive Director, Prof. (Dr.) Ajai Singh, and Patanjali Research Institute’s Chief Scientist, Dr. Anurag Varshney. The partnership will focus on collaborative research in critical areas such as fatty liver disease, allergies, lifestyle-related disorders, liver ailments, respiratory issues, kidney diseases, and neurological disorders. A key point of discussion during the event was the clinical controlled trials of Patanjali’s evidence-based Ayurvedic medicines, Livogrit and Bronchom.

Prof. (Dr.) Ajai Singh highlighted that this agreement signifies a new chapter in healthcare, combining the strengths of modern medical science with traditional Indian knowledge to deliver more effective, accessible, and holistic treatment options. He also announced that the Patanjali Research Foundation Trust will establish the largest herbal garden in Madhya Pradesh within the AIIMS Bhopal campus, providing a valuable resource for research and academic pursuits.

Dr. Anurag Varshney credited the blessings of Param Pujya Swami Ramdev Ji and the inspiration of Param Shraddhey Acharya Balkrishna Ji for driving this collaboration, which he described as a significant move toward positioning Patanjali Ayurveda on the global stage.

Prof. (Dr.) Ashok Kumar, a key organizer of the event, called the initiative a milestone in India’s journey toward self-reliance and empowerment in medicine, emphasizing that it exemplifies the successful integration of modernity and ancient wisdom.

Also present at the event were AIIMS Bhopal’s Dean (Research) Prof. (Dr.) Rehan-UI-Haq, Dean (Academics) Prof. (Dr.) Rajnish Joshi, Prof. (Dr.) Ashok Kumar, and several other senior officials and scientists.

Related Posts

Civil society group SAM calls for greater transparency involving clinical trials

The group had approached the Supreme Court, raising concerns on clinical trials in a Public Interest Litigation in 2012 Civil society group Swasthya Adhikar Manch (SAM) has called for greater…

Different packaging, typos expose fake Mounjaro racket

Gurugram: Colour dissimilarity to typographical errors… conspicuous differences in the packaging of counterfeit Mounjaro injections led the Drugs Control Office to crack down on the illicit sale and production of…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Civil society group SAM calls for greater transparency involving clinical trials

Civil society group SAM calls for greater transparency involving clinical trials

Different packaging, typos expose fake Mounjaro racket

Different packaging, typos expose fake Mounjaro racket

To Eat or not to Eat, if this Dilemma is ‘Eating’ you, ‘Eat’ this Book

To Eat or not to Eat, if this Dilemma is ‘Eating’ you, ‘Eat’ this Book

NCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 crore

NCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 crore

Rajasthan Bans 7 Sub-Standard Medicines

Rajasthan Bans 7 Sub-Standard Medicines

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection